
Alpha Profiles · Company Profile
PLIANT THERAPEUTICS, INC.
Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States.
https://registry.alpha.ac/companies/pliant-therapeutics-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: PLRX
- Verification
- Partially verified
- Last reviewed
- 2026-10-05T15:32:23.925467+00:00
Overview
Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States. Its flagship investigational product, PLN-74809, is an orally administered, small-molecule, dual-selective inhibitor targeting both avß6 and avß1 integrins, which is currently progressing through three distinct Phase 2a clinical trials.
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-05T15:32:23.925467+00:00
